Evidence map›Paper›PMID 39687737›Full record

ArticleFrontiers in genetics2024

Fatty acid traits mediate the effects of uric acid on cancers: a Mendelian randomization study.

Jianing Li, Yongsheng Zhang, Tong Fu, Songyan Wang, Hongbo Cai, Fenghua Xu, Guoli Xing, Ying Tong

Abstract read
In one paragraph

Article in Frontiers in genetics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jianing LiHeilongjiang University of Chinese Medicine, Harbin, China.
Yongsheng ZhangHarbin Institute of Technology, Harbin, China.
Tong FuBrandeis University, Waltham, MA, United States.
Songyan WangFirst Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin, China.
Hongbo CaiFirst Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin, China.
Fenghua XuFirst Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin, China.
Guoli XingFirst Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin, China.
Ying TongFirst Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Previous findings on the association between uric acid (UA) levels and cancer risk are conflicting. Moreover, the mechanisms underlying the interactions between UA levels, fatty acid traits, and cancer outcomes remain complex; it is still unclear whether elevated UA levels influence fatty acid traits and, thereby, contribute to an increased cancer risk. Therefore, we aimed to investigate the association between UA levels and cancer risk, with a specific focus on the potential mediating role of fatty acid traits. Methods: We employed a Mendelian randomization (MR) analysis utilizing genetic data from large-scale genome-wide association studies to assess the causal relationships among UA levels, fatty acid traits, and cancer risk. The primary method used was the inverse variance-weighted approach alongside Bayesian-weighted Mendelian randomization. Other MR models were also applied for comparison. Sensitivity analyses, based on various statistical assumptions, were also performed to evaluate the robustness of the findings. A two-step MR analysis was conducted to explore the mediating effects of fatty acid traits on the relationship between UA levels and cancer risk. Results and Discussion: Elevated UA levels were associated with an increased risk of

Indexed as

cancerfatty acidsmediateMendelian randomizationuric acid

Identifiers

PMID39687737
PMCPMC11646984

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.